secwatch.observer — SEC 8-K summary
======================================

Issuer:     LifeStance Health Group, Inc. (LFST)
CIK:        0001845257
Form:       8-K
Filed at:   2022-09-08T23:59:59+00:00
Accession:  0001193125-22-240642
Event type: leadership
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

LifeStance appoints Ken Burdick as CEO/Chairman; founding CEO Michael Lester retires
--------------------------------------------------------------------------------

- Ken Burdick appointed CEO and Chairman effective Sept 7, 2022; succeeds Michael Lester who retires as officer and director.
- Danish Qureshi named President in addition to his role as COO.
- Lester's Alert5 Consulting LLC receives $50,933.33/month consulting fee through Sept 7, 2023.
- Burdick gets $700,000 base salary, target bonus 100% of base, and option for 9,404,539 shares with time/performance vesting.
- Qureshi receives option for 2,821,362 shares with one-third time-based and two-thirds performance-based vesting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1845257/000119312522240642/0001193125-22-240642-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1845257/000119312522240642/d320877d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-240642

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer